The Death Domain Kinase RIP1 Links the Immunoregulatory CD40 Receptor to Apoptotic Signaling in Carcinomas

Journal of Cell Biology - United States
doi 10.1083/jcb.201003087
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Rockefeller University Press

Related search

Signaling Functions of the CD40 Receptor 36

Pediatric Research
Child HealthPediatricsPerinatology
1996English

Non-Canonical Kinase Signaling by the Death Ligand TRAIL in Cancer Cells: Discord in the Death Receptor Family

Cell Death and Differentiation
Cell BiologyMolecular Biology
2013English

Death Domain Signaling by Disulfide-Linked Dimers of the P75 Neurotrophin Receptor Mediates Neuronal Death in the CNS

Journal of Neuroscience
Neuroscience
2016English

Dual Signaling of the Fas Receptor: Initiation of Both Apoptotic and Necrotic Cell Death Pathways

Journal of Experimental Medicine
MedicineAllergyImmunology
1998English

Non-Apoptotic Cell Death Signaling Pathways in Melanoma

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2020English

Dangerous Liaisons: The Apoptotic Engulfment Receptor CED-1 Links Innate Immunity to the Unfolded Protein Response

Developmental Cell
BiochemistryDevelopmental BiologyGeneticsCell BiologyMolecular Biology
2008English

CD40 Ligand Induces RIP1-dependent, Necroptosis-Like Cell Death in Low-Grade Serous but Not Serous Borderline Ovarian Tumor Cells

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2015English

Downregulation of Sef, an Inhibitor of Receptor Tyrosine Kinase Signaling, Is Common to a Variety of Human Carcinomas

Oncogene
Cancer ResearchGeneticsMolecular Biology
2007English

Ubiquitination of RIP1 Regulates an NF-κB-Independent Cell-Death Switch in TNF Signaling

Current Biology
GeneticsMolecular BiologyBiochemistryBiological SciencesNeuroscienceAgricultural
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy